Sanofi (SNY) wins FDA label expansion for its MenQuadfi meningococcal vaccine for use in infants as young as six weeks. Read ...

HHS Secretary Robert F. Kennedy Jr. threatened to bar NIH scientists from publishing in leading medical journals, saying the ...

The U.S. FDA has approved an expanded indication for Sanofi (NASDAQ:SNY)’s quadrivalent meningococcal vaccine, MenQuadfi, now ...

French drugmaker Sanofi said the U.S. Food and Drug Administration has approved its meningococcal vaccine for use in infants ...

Sanofi Eyes Extension of Meningococcal Disease Shot to Infants, Toddlers Sanofi’s meningococcal disease vaccine MenQuadfi is currently approved for the primary immunization of children aged two years ...

While it’s largely preventable through vaccines such as Sanofi’s own MenQuadfi, infection of the most severe form, bacterial meningitis, can be fatal within just 24 hours and remains a ...

Do use purpose-built or “pharmaceutical grade” refrigerators or freezers; if not available, can use stand-alone household units. Don’t use dormitory-style or bar-style combined refrigerator ...

LONDON, GREATER LONDON, UNITED KINGDOM, March 12, 2025 /EINPresswire / -- How Has the Market Grown in Recent Years and What Is the Projected Market Size? The MenQuadfi market has been experiencing ...

Prescription Drug Price Increases Range from 1.89% to 10.17% FAYETTEVILLE, NY, UNITED STATES, December 20, 2024 /EINPresswire.com/ -- The beginning of the year is ...

Please note: All practitioners who are competent in hepatitis and typhoid vaccine assessment and delivery, should ensure they have read and have self-declared as competent in the separate Typhoid and ...